GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » PE Ratio (TTM)

Zylox-Tonbridge Medical Technology Co (HKSE:02190) PE Ratio (TTM) : 149.38 (As of Mar. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2025-03-02), Zylox-Tonbridge Medical Technology Co's share price is HK$12.10. Zylox-Tonbridge Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.08. Therefore, Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) for today is 149.38.


The historical rank and industry rank for Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) or its related term are showing as below:

HKSE:02190' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: 172.1
Current: 149.38


During the past 5 years, the highest PE Ratio (TTM) of Zylox-Tonbridge Medical Technology Co was 172.10. The lowest was 0.00. And the median was 0.00.


HKSE:02190's PE Ratio (TTM) is ranked worse than
94.57% of 405 companies
in the Medical Devices & Instruments industry
Industry Median: 26.62 vs HKSE:02190: 149.38

Zylox-Tonbridge Medical Technology Co's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was HK$0.23. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.08.

As of today (2025-03-02), Zylox-Tonbridge Medical Technology Co's share price is HK$12.10. Zylox-Tonbridge Medical Technology Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.15. Therefore, Zylox-Tonbridge Medical Technology Co's PE Ratio without NRI for today is 83.45.

During the past 5 years, Zylox-Tonbridge Medical Technology Co's highest PE Ratio without NRI was 97.76. The lowest was 0.00. And the median was 0.00.

Zylox-Tonbridge Medical Technology Co's EPS without NRI for the six months ended in Jun. 2024 was HK$0.25. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.15.

During the past 3 years, the average EPS without NRI Growth Rate was 14.70% per year.

During the past 5 years, Zylox-Tonbridge Medical Technology Co's highest 3-Year average EPS without NRI Growth Rate was 14.70% per year. The lowest was -15.10% per year. And the median was -0.20% per year.

Zylox-Tonbridge Medical Technology Co's EPS (Basic) for the six months ended in Jun. 2024 was HK$0.23. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.08.


Zylox-Tonbridge Medical Technology Co PE Ratio (TTM) Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co PE Ratio (TTM) Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio (TTM)
N/A N/A At Loss At Loss At Loss

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM)

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) falls into.



Zylox-Tonbridge Medical Technology Co PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=12.10/0.081
=149.38

Zylox-Tonbridge Medical Technology Co's Share Price of today is HK$12.10.
For company reported semi-annually, Zylox-Tonbridge Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Zylox-Tonbridge Medical Technology Co  (HKSE:02190) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Zylox-Tonbridge Medical Technology Co PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zylox-Tonbridge Medical Technology Co Business Description

Traded in Other Exchanges
Address
270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).
Executives
Wang Stephen Hui 2201 Interest of corporation controlled by you
Hang Zhou Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo 2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo 2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo 2401 A concert party to an agreement to buy shares
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2401 A concert party to an agreement to buy shares
Wea Enterprises, Llc 2401 A concert party to an agreement to buy shares
Zhong Shengping Sam 2401 A concert party to an agreement to buy shares
Zhao Jonathon Zhong 2501 Other
Wei Na 2501 Other
Li Zheng 2501 Other
Schroders Plc 2102 Investment manager
Ourea Biotech Hk Limited 2501 Other
Highlight Medical Limited 2501 Other
Five Investment Limited 2501 Other

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines